{"id":2410,"date":"2018-05-29T00:00:00","date_gmt":"2018-05-29T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2410"},"modified":"2018-05-29T00:00:00","modified_gmt":"2018-05-29T00:00:00","slug":"acuerdo-con-aldeyra-therapeutics","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/es\/agreement-with-aldeyra-therapeutics\/","title":{"rendered":"Acuerdo con Aldeyra Therapeutics"},"content":{"rendered":"<p>CENTOGENE anunci\u00f3 hoy que ha firmado un acuerdo con <a href=\"https:\/\/www.aldeyra.com\/\" target=\"_blank\" title=\"Obtenga m\u00e1s informaci\u00f3n\">Aldeyra Therapeutics Inc<\/a>., una empresa de biotecnolog\u00eda que desarrolla medicamentos de pr\u00f3xima generaci\u00f3n para mejorar la vida de los pacientes con enfermedades inmunomediadas.<\/p>\n<p>Seg\u00fan los t\u00e9rminos del acuerdo, CENTOGENE colaborar\u00e1 con Aldeyra para identificar globalmente a pacientes con SLS y comprender el espectro cl\u00ednico de esta enfermedad. El objetivo del acuerdo es apoyar a m\u00e9dicos y pacientes con un diagn\u00f3stico temprano mediante pruebas gen\u00e9ticas que podr\u00edan conducir a la identificaci\u00f3n de nuevos desarrollos terap\u00e9uticos y a la concienciaci\u00f3n sobre la enfermedad.<\/p>\n<p>\u201cLa mayor\u00eda de los pacientes con una enfermedad hereditaria rara atraviesan una considerable odisea diagn\u00f3stica antes de tener certeza sobre su condici\u00f3n. El conocimiento global sobre el SLS es muy limitado, lo que significa que los m\u00e9dicos a menudo ni siquiera piensan en el SLS al enfrentarse a los s\u00edntomas del paciente y, en consecuencia, no realizan las pruebas gen\u00e9ticas necesarias. Este desaf\u00edo es un excelente ejemplo de c\u00f3mo nuestra base de datos de conocimiento profundo y global (CentoMD\u00ae) puede aportar un enorme beneficio como soluci\u00f3n de atenci\u00f3n m\u00e9dica universal a la comunidad de enfermedades raras, afirm\u00f3 el Dr. Arndt Rolfs, director ejecutivo y fundador de CENTOGENE.<\/p>\n<p>\u201cLa colaboraci\u00f3n con CENTOGENE complementa el Registro Aldeyra para Pacientes con SLS, dise\u00f1ado para unir a los pacientes y concienciar a nivel mundial sobre la enfermedad\u201d, afirm\u00f3 David Clark, MD, MRCP, AFPM, Director M\u00e9dico de Aldeyra. \u201cAdem\u00e1s, el acceso a la base de datos gen\u00e9tica de CENTOGENE para pacientes con SLS demuestra el papel crucial de la gen\u00e9tica en la identificaci\u00f3n de pacientes y el desarrollo de medicamentos para enfermedades donde no existen tratamientos\u201d.\u201d<\/p>\n<p>El SLS se hereda de forma autos\u00f3mica recesiva y los pacientes presentan un amplio espectro de s\u00edntomas, incluyendo ictiosis (piel muy seca, engrosada y escamosa), piernas espaciadas y retraso cognitivo. Los pacientes con SLS no pueden descomponer adecuadamente las mol\u00e9culas llamadas aldeh\u00eddos grasos, lo que resulta en una acumulaci\u00f3n anormal de estas mol\u00e9culas, lo que provoca los s\u00edntomas de la enfermedad. Actualmente no existe un tratamiento aprobado por la FDA para el SLS.<\/p>\n<h5>Acerca de CENTOGENE<\/h5>\n<p>CENTOGENE aprovecha el poder del conocimiento gen\u00e9tico para mejorar la calidad de vida de los pacientes con enfermedades gen\u00e9ticas raras. Lo logramos gracias al conocimiento generado por nuestros servicios globales de pruebas diagn\u00f3sticas, que incorporan diversidad global, la base de datos patentada de interpretaci\u00f3n gen\u00e9tica humana l\u00edder a nivel mundial, CentoMD\u00ae, y soluciones para compa\u00f1\u00edas farmac\u00e9uticas que desarrollan medicamentos hu\u00e9rfanos que cambian la vida.<\/p>\n<p>Como una de las empresas de pruebas gen\u00e9ticas m\u00e1s grandes y diversificadas del mundo, CENTOGENE se dedica a transformar la ciencia de la informaci\u00f3n gen\u00e9tica en soluciones y esperanza para los pacientes y sus familias.<\/p>\n<p><a class=\"btn btn-secondary btn-sm\" href=\"https:\/\/www.centogene.com\/es\/\" target=\"_blank\" title=\"M\u00e1s sobre Centogene\">www.centogene.com<\/a>&nbsp;<a class=\"btn btn-secondary btn-sm\" href=\"https:\/\/www.centoMD.com\" target=\"_blank\" title=\"M\u00e1s sobre CentoMD\">www.centoMD.com<\/a><\/p>\n<h5>Acerca del s\u00edndrome de Sj\u00f6gren-Larsson<\/h5>\n<p>El s\u00edndrome de Sj\u00f6gren-Larsson es un error innato poco com\u00fan del metabolismo de los aldeh\u00eddos, causado por mutaciones en la aldeh\u00eddo deshidrogenasa de \u00e1cidos grasos. Esto provoca niveles elevados de aldeh\u00eddos grasos t\u00f3xicos que se cree que contribuyen a la ictiosis grave (piel escamosa, engrosada y seca), trastornos neurol\u00f3gicos y enfermedades de la retina. No existe un tratamiento para el SLS aprobado por la Administraci\u00f3n de Alimentos y Medicamentos de EE. UU.<\/p>","protected":false},"excerpt":{"rendered":"<p>CENTOGENE anunci\u00f3 hoy que ha firmado un acuerdo con Aldeyra Therapeutics Inc., una empresa de biotecnolog\u00eda que desarrolla medicamentos de pr\u00f3xima generaci\u00f3n para mejorar la vida de los pacientes con enfermedades inmunomediadas.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2410","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agreement with Aldeyra Therapeutics | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/acuerdo-con-aldeyra-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agreement with Aldeyra Therapeutics | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CENTOGENE today announced that it has entered into an agreement with Aldeyra Therapeutics Inc., a biotechnology company developing next-generation medicines to improve the lives of patients with immune-mediated diseases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/acuerdo-con-aldeyra-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-29T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"Agreement with Aldeyra Therapeutics\",\"datePublished\":\"2018-05-29T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/\"},\"wordCount\":484,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/\",\"name\":\"Agreement with Aldeyra Therapeutics | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2018-05-29T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/agreement-with-aldeyra-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agreement with Aldeyra Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/es\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acuerdo con Aldeyra Therapeutics | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/acuerdo-con-aldeyra-therapeutics\/","og_locale":"es_ES","og_type":"article","og_title":"Agreement with Aldeyra Therapeutics | CENTOGENE","og_description":"CENTOGENE today announced that it has entered into an agreement with Aldeyra Therapeutics Inc., a biotechnology company developing next-generation medicines to improve the lives of patients with immune-mediated diseases.","og_url":"https:\/\/www.centogene.com\/es\/acuerdo-con-aldeyra-therapeutics\/","og_site_name":"CENTOGENE","article_published_time":"2018-05-29T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"Agreement with Aldeyra Therapeutics","datePublished":"2018-05-29T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/"},"wordCount":484,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/","url":"https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/","name":"Acuerdo con Aldeyra Therapeutics | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2018-05-29T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/agreement-with-aldeyra-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"Agreement with Aldeyra Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"administrador","url":"https:\/\/www.centogene.com\/es\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=2410"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2410\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=2410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/categories?post=2410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/tags?post=2410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}